Expression and function of the rat vesicular monoamine transporter 2

American Journal of Physiology - Cell Physiology

Volumn 294, Issue 4, 2008, Pages

  Adam, Yoav ^a   Edwards, Robert H ^b   Schuldiner, Shimon ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ion coupled transporters; Membrane protein; Monoamines; Neurotransmitter storage

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; GLYCOPROTEIN P; MONOAMINE; NEUROTOXIN; SEROTONIN; SEROTONIN TRANSPORTER; TETRABENAZINE; VESICULAR MONOAMINE TRANSPORTER 2;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOLIPOSOME; SOLUBILIZATION; SYNAPSE VESICLE; TURNOVER TIME; WESTERN BLOTTING;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELL LINE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; RATS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

RATTUS;

EID: 41949089632     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00348.2007     Document Type: Article

References (42)

1. Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, Iwata S. Structure and mechanism of the lactose permease of Escherichia coli. Science 301: 610-615, 2003.
2. Durocher Y, Perret S, Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30: E9, 2002.
3. Eiden LE. The vesicular neurotransmitter transporters: current perspectives and future prospects. FASEB J 14: 2396-2400, 2000.
4. Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93: 5166-5171, 1996.
5. Fon EA, Pothos EN, Sun BC, Killeen N, Sulzer D, Edwards RH. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19: 1271-1283, 1997.
6. Glatt CE, Wahner AD, White DJ, Ruiz-Linares A, Ritz B. Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women. Hum Mol Genet 15: 299-305, 2006.
7. Gopalakrishnan A, Sievert M, Ruoho AE. Identification of the substrate binding region of vesicular monoamine transporter-2 (VMAT-2) using iodoaminoflisopolol as a novel photoprobe. Mol Pharmacol 72: 1567-1575, 2007.
8. Henry JP, Scherman D. Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles. Biochem Pharmacol 38: 2395-2404, 1989.
9. Hirai T, Heymann JAW, Maloney PC, Subramaniam S. Structural model for 12-helix transporters belonging to the major facilitator superfamily. J Bacteriol 185: 1712-1718, 2003.
10. Howell M, Shirvan A, Stern-Bach Y, Steiner-Mordoch S, Strasser JE, Dean GE, Schuldiner S. Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules. FEBS Lett 338: 16-22, 1994.
11. Huang Y, Lemieux MJ, Song J, Auer M, Wang DN. Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301: 616-620, 2003.
12. Kenney C, Jankovic J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Rev Neurother 6: 7-17, 2006.
13. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
14. + toxicity encodes a vesicular amine transporter. Cell 70: 539-551, 1992.
15. Liu Y, Roghani A, Edwards R. Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4- phenylpyridinium. Proc Natl Acad Sci USA 89: 9074-9078, 1992.
16. Merickel A, Kaback HR, Edwards RH. Charged residues in transmembrane domains II and XI of a vesicular monoamine transporter form a charge pair that promotes high affinity substrate recognition. J Biol Chem 272: 5403-5408, 1997.
17. Pao SS, Paulsen IT, Saier, MH Jr. Major facilitator superfamily. Microbiol Mol Biol Rev 62: 1-34, 1998.
18. Peter D, Jimenez J, Liu Y, Kim J, Edwards RH. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J Biol Chem 269: 7231-7237, 1994.
19. Reeves PJ, Thurmond RL, Khorana HG. Structure and function in rhodopsin: high level expression of a synthetic bovine opsin gene and its mutants in stable mammalian cell lines. Proc Natl Acad Sci USA 93: 11487-11492, 1996.
20. Rudnick G, Steiner-Mordoch SS, Fishkes H, Stern-Bach Y, Schuldiner S. Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter. Biochemistry 29: 603-608, 1990.
21. Scherman D. Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions. J Neurochem 47: 331-339, 1986.
22. Scherman D, Jaudon P, Henry JP. Characterization of the monoamine carrier of chromaffin granule membrane by binding of [2-3H]dihydrotetrabenazine. Proc Natl Acad Sci USA 80: 584-588, 1983.
23. Schuldiner S, Liu Y, Edwards RH. Reserpine binding to a vesicular amine transporter expressed in Chinese hamster ovary fibroblasts. J Biol Chem 268: 29-34, 1993.
24. Schuldiner S, Shirvan A, Linial M. Vesicular neurotransmitter transporters: from bacteria to humans. Physiol Rev 75: 369-392, 1995.
25. Shirvan A, Laskar O, Steiner-Mordoch S, Schuldiner S. Histidine-419 plays a role in energy coupling in the vesicular monoamine transporter from rat. FEBS Lett 356: 145-150, 1994.
26. Sievert MK, Hajipour AR, Ruoho AE. Specific derivatization of the vesicle monoamine transporter with novel carrier-free radioiodinated reserpine and tetrabenazine photoaffinity labels. Anal Biochem 367: 68-78, 2007.
27. Sievert MK, Thiriot DS, Edwards RH, Ruoho AE. High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells. Biochem J 330: 959-966, 1998.
28. Stern-Bach Y, Greenberg-Ofrath N, Flechner I, Schuldiner S. Identification and purification of a functional amine transporter from bovine chromaffin granules. J Biol Chem 265: 3961-3966, 1990.
29. Stern-Bach Y, Keen JN, Bejerano M, Steiner-Mordoch S, Wallach M, Findlay JB, Schuldiner S. Homology of a vesicular amine transporter to a gene conferring resistance to 1-methyl-4-phenylpyridinium. Proc Natl Acad Sci USA 89: 9730-9733, 1992.
30. Suchi R, Stern-Bach Y, Gabay T, Schuldiner S. Covalent modification of the amine transporter with N,N′- dicyclohexylcarbodiimide. Biochemistry 30: 6490-6494, 1991.
31. Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl GR. VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci USA 94: 9938-9943, 1997.
32. Tate CG, Haase J, Baker C, Boorsma M, Magnani F, Vallis Y, Williams DC. Comparison of seven different heterologous protein expression systems for the production of the serotonin transporter. Biochim Biophys Acta 1610: 141-153, 2003.
33. Vardy E, Arkin IT, Gottschalk KE, Kaback HR, Schuldiner S. Structural conservation in the major facilitator superfamily as revealed by comparative modeling. Protein Sci 13: 1832-1840, 2004.
34. Volz TJ, Hanson GR, Fleckenstein AE. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry. J Neurosci Methods 155: 109-115, 2006.
35. Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19: 1285-1296, 1997.
36. West M, Park D, Dodd JR, Kistler J, Christie DL. Purification and characterization of the creatine transporter expressed at high levels in HEK293 cells. Protein Expr Purif 41: 393-401, 2005.
37. Whitley J, Parsons J, Freeman J, Liu Y, Edwards RH, Near JA. Electrochemical monitoring of transport by a vesicular monoamine transporter expressed in Xenopus oocytes. J Neurosci Methods 133: 191-199, 2004.
38. --dependent neurotransmitter transporters. Nature 437: 215-223, 2005.
39. Yelin R, Schuldiner S. The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters. FEBS Lett 377: 201-207, 1995.
40. Yelin R, Schuldiner S. Vesicular monoamine transporters heterologously expressed in the yeast Saccharomyces cerevisiae display high-affinity tetrabenazine binding. Biochim Biophys Acta 1510: 426-441, 2001.
41. Yelin R, Steiner-Mordoch S, Aroeti B, Schuldiner S. Glycosylation of a vesicular monoamine transporter: a mutation in a conserved proline residue affects the activity, glycosylation, and localization of the transporter. J Neurochem 71: 2518-2527, 1998.
42. Yernool D, Boudker O, Jin Y, Gouaux E. Structure of a glutamate transporter homologue from Pyrococcus horikoshii. Nature 431: 811-818, 2004.